Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Natural History Study Protocol in PMM2-CDG (CDG-Ia)

View source ↗

Summary

This document describes a natural history study protocol for PMM2-CDG (phosphomannomutase 2 deficiency) sponsored by Glycomine, Inc., with status listed as acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Glycomine, Inc. | Conditions: Phosphomannomutase 2 Deficiency | Status: ACTIVE_NOT_RECRUITING